Investment Summary |
|
|---|---|
| Date | 2025-03-24 |
| Target | Enhanced Medical Nutrition |
| Sector | Consumer Products |
| Investor(s) | Ajinomoto |
| Deal Type | Growth Capital |
SEARCH BY
Ajinomoto is a manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. Ajinomoto was incorporated in 1909 and is based in Tokyo, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 10 |
| Sector: Consumer Products M&A | 1 of 1 |
| Type: Growth Capital M&A Deals | 1 of 1 |
| State: Ontario M&A | 1 of 1 |
| Country: Canada M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-11-13 |
Forge Biologics
Grove City, Ohio, United States Forge Biologics is a viral vector and plasmid contract development and manufacturing organization (CDMO) and clinical-stage therapeutics company, enabling access to potentially life-changing gene therapies by bringing them from concept to reality. Forge Biologics was founded in 2020 and is based in Grove City, Ohio. |
Buy | $620M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-04-24 |
Althea
San Diego, California, United States Althea is a fully integrated, contract development and manufacturing organization providing clinical and commercial product development services. The company offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, complex formulation, product release, and ICH-compliant stability testing. Its formulation technology platform includes Crystalomics, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. Althea is based in San Diego, California. |
Sell | - |
